|
Submit Tools | Thread Tools | Search this Thread | Display Modes |
#1
|
|||
|
|||
IGXT (Mcap $29 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013
THIS UNKNOWN GEM IS DEFINITELY THE CHEAPEST STOCK IN THE BIOTECH SECTOR .PLEASE DO YOUR OWN DD AND REALIZE THE MEGA MONSTER POTENTIAL GLTA
Intelgenx launched their first drug Forfivo in October this will push this unknown Gem into Profitability by mid 2013 because of its very low burn-rate of $1.2 Mil a year ! 2x New NDA filings for Migraine and Erectile Dysfunction indication in early 2013 . This Goldmine has 9x Drugs in their Mega Pipeline which will be all on the Market within next 2-3 years (see pipeline chart below) ! IGXT has NO DEBT and current Market cap of only $29 M is really a BIG BIG BARGAIN . My Target is $8-12 within 2 Years .GLTA Intelgenx (IGXT.OB) Market Cap : $ 29 M Cash: $ 3 M ( Burn-rate only $1.2 M a year ) Price : 0.59 $ Shares Out : 50 M ( 26 M shares are held by Insiders + Institutions) Fantastic Prodcut Pipeline Latest Presentation Oct 2012 Big Buying by Institutions Analyst Coverage: IGXT gets 18 month $3.00 Price Target from AEGIS CAPITAL CORP on October 5th, 2012 The Event- Forfivo XL is now officially launched in the US IntelGenx striving to create a second Biovail IntelGenx to file anti-migraine NDA in first 2013 IntelGenx |
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
Thread Tools | Search this Thread |
Display Modes | |
|
|